Similar to the discovery cohort, an increased CD8+ T cell density was demonstrated within the tumor immune microenvironment of localized ccRCC tumors that did not progress compared to those that did progress (median 330.6 cells/mm2 vs. 181.5 cells/mm2, p = 0.004). This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.